ID   FABP5_HUMAN             Reviewed;         135 AA.
AC   Q01469; B2R4K0;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 193.
DE   RecName: Full=Fatty acid-binding protein, epidermal;
DE   AltName: Full=Epidermal-type fatty acid-binding protein;
DE            Short=E-FABP;
DE   AltName: Full=Fatty acid-binding protein 5;
DE   AltName: Full=Psoriasis-associated fatty acid-binding protein homolog;
DE            Short=PA-FABP;
GN   Name=FABP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Keratinocyte;
RX   PubMed=1512466; DOI=10.1111/1523-1747.ep12616641;
RA   Madsen P.S., Rasmussen H.H., Leffers H., Honore B., Celis J.E.;
RT   "Molecular cloning and expression of a novel keratinocyte protein
RT   (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is
RT   highly up-regulated in psoriatic skin and that shares similarity to
RT   fatty acid-binding proteins.";
RL   J. Invest. Dermatol. 99:299-305(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-10, AND ACETYLATION AT ALA-2.
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 18-33; 35-50; 62-103 AND 116-129, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 25-33; 39-50; 62-71; 83-101 AND 120-129.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 67-72 AND 104-110, AND CHARACTERIZATION.
RX   PubMed=8092987; DOI=10.1042/bj3020363;
RA   Siegenthaler G., Hotz R., Chatellard-Gruaz D., Didierjean L.,
RA   Hellman U., Saurat J.-H.;
RT   "Purification and characterization of the human epidermal fatty acid-
RT   binding protein: localization during epidermal cell differentiation in
RT   vivo and in vitro.";
RL   Biochem. J. 302:363-371(1994).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-131, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) IN COMPLEX WITH FATTY ACID, AND
RP   DISULFIDE BOND.
RX   PubMed=10493790; DOI=10.1021/bi990305u;
RA   Hohoff C., Borchers T., Rustow B., Spener F., van Tilbeurgh H.;
RT   "Expression, purification and crystal structure determination of
RT   recombinant human epidermal-type fatty acid-binding protein.";
RL   Biochemistry 38:12229-12239(1999).
RN   [18]
RP   STRUCTURE BY NMR, AND DISULFIDE BOND.
RX   PubMed=12049637; DOI=10.1042/BJ20020039;
RA   Gutierrez-Gonzalez L.H., Ludwig C., Hohoff C., Rademacher M.,
RA   Hanhoff T., Rueterjans H., Spener F., Luecke C.;
RT   "Solution structure and backbone dynamics of human epidermal-type
RT   fatty acid-binding protein (E-FABP).";
RL   Biochem. J. 364:725-737(2002).
CC   -!- FUNCTION: High specificity for fatty acids. Highest affinity for
CC       C18 chain length. Decreasing the chain length or introducing
CC       double bonds reduces the affinity. May be involved in keratinocyte
CC       differentiation.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Keratinocytes; highly expressed in psoriatic
CC       skin.
CC   -!- DOMAIN: Forms a beta-barrel structure that accommodates the
CC       hydrophobic ligand in its interior.
CC   -!- SIMILARITY: Belongs to the calycin superfamily. Fatty-acid binding
CC       protein (FABP) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M94856; AAA58467.1; -; mRNA.
DR   EMBL; BT007449; AAP36117.1; -; mRNA.
DR   EMBL; AK311856; BAG34797.1; -; mRNA.
DR   EMBL; CH471068; EAW87088.1; -; Genomic_DNA.
DR   EMBL; BC019385; AAH19385.1; -; mRNA.
DR   EMBL; BC070303; AAH70303.1; -; mRNA.
DR   CCDS; CCDS6228.1; -.
DR   PIR; I56326; I56326.
DR   RefSeq; NP_001435.1; NM_001444.2.
DR   UniGene; Hs.408061; -.
DR   PDB; 1B56; X-ray; 2.05 A; A=1-135.
DR   PDB; 1JJJ; NMR; -; A=1-135.
DR   PDB; 4AZM; X-ray; 2.75 A; A/B=1-135.
DR   PDB; 4AZR; X-ray; 2.95 A; A/B=1-135.
DR   PDB; 4LKP; X-ray; 1.67 A; A=1-135.
DR   PDB; 4LKT; X-ray; 2.57 A; A/B/C/D=1-135.
DR   PDB; 5HZ5; X-ray; 1.40 A; A=2-135.
DR   PDBsum; 1B56; -.
DR   PDBsum; 1JJJ; -.
DR   PDBsum; 4AZM; -.
DR   PDBsum; 4AZR; -.
DR   PDBsum; 4LKP; -.
DR   PDBsum; 4LKT; -.
DR   PDBsum; 5HZ5; -.
DR   ProteinModelPortal; Q01469; -.
DR   SMR; Q01469; -.
DR   BioGrid; 108469; 38.
DR   IntAct; Q01469; 2.
DR   MINT; MINT-3024261; -.
DR   STRING; 9606.ENSP00000297258; -.
DR   BindingDB; Q01469; -.
DR   ChEMBL; CHEMBL3674; -.
DR   DrugBank; DB03796; Palmitic Acid.
DR   GuidetoPHARMACOLOGY; 2535; -.
DR   SwissLipids; SLP:000001104; -.
DR   TCDB; 8.A.33.1.1; the fatty acid binding protein (fabp) family.
DR   iPTMnet; Q01469; -.
DR   PhosphoSitePlus; Q01469; -.
DR   SwissPalm; Q01469; -.
DR   BioMuta; FABP5; -.
DR   DMDM; 232081; -.
DR   SWISS-2DPAGE; Q01469; -.
DR   UCD-2DPAGE; Q01469; -.
DR   EPD; Q01469; -.
DR   MaxQB; Q01469; -.
DR   PaxDb; Q01469; -.
DR   PeptideAtlas; Q01469; -.
DR   PRIDE; Q01469; -.
DR   TopDownProteomics; Q01469; -.
DR   DNASU; 2171; -.
DR   Ensembl; ENST00000297258; ENSP00000297258; ENSG00000164687.
DR   GeneID; 2171; -.
DR   KEGG; hsa:2171; -.
DR   UCSC; uc003yca.3; human.
DR   CTD; 2171; -.
DR   DisGeNET; 2171; -.
DR   GeneCards; FABP5; -.
DR   HGNC; HGNC:3560; FABP5.
DR   HPA; CAB017831; -.
DR   HPA; CAB040577; -.
DR   HPA; HPA051895; -.
DR   MIM; 605168; gene.
DR   neXtProt; NX_Q01469; -.
DR   OpenTargets; ENSG00000164687; -.
DR   PharmGKB; PA27961; -.
DR   eggNOG; KOG4015; Eukaryota.
DR   eggNOG; ENOG4111US8; LUCA.
DR   GeneTree; ENSGT00760000118898; -.
DR   HOGENOM; HOG000004829; -.
DR   HOVERGEN; HBG005633; -.
DR   InParanoid; Q01469; -.
DR   KO; K08754; -.
DR   OMA; VECDMNG; -.
DR   OrthoDB; EOG091G0QSV; -.
DR   PhylomeDB; Q01469; -.
DR   TreeFam; TF316894; -.
DR   Reactome; R-HSA-163560; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   EvolutionaryTrace; Q01469; -.
DR   GeneWiki; FABP5; -.
DR   GenomeRNAi; 2171; -.
DR   PRO; PR:Q01469; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000164687; -.
DR   CleanEx; HS_FABP5; -.
DR   ExpressionAtlas; Q01469; baseline and differential.
DR   Genevisible; Q01469; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0005504; F:fatty acid binding; TAS:ProtInc.
DR   GO; GO:0008289; F:lipid binding; TAS:ProtInc.
DR   GO; GO:0005215; F:transporter activity; IEA:InterPro.
DR   GO; GO:0008544; P:epidermis development; TAS:ProtInc.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0015758; P:glucose transport; IEA:Ensembl.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEA:Ensembl.
DR   GO; GO:0019433; P:triglyceride catabolic process; TAS:Reactome.
DR   Gene3D; 2.40.128.20; -; 1.
DR   InterPro; IPR012674; Calycin.
DR   InterPro; IPR000463; Fatty_acid-bd.
DR   InterPro; IPR031259; ILBP.
DR   InterPro; IPR000566; Lipocln_cytosolic_FA-bd_dom.
DR   PANTHER; PTHR11955; PTHR11955; 1.
DR   Pfam; PF00061; Lipocalin; 1.
DR   PRINTS; PR00178; FATTYACIDBP.
DR   SUPFAM; SSF50814; SSF50814; 1.
DR   PROSITE; PS00214; FABP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Lipid-binding;
KW   Phosphoprotein; Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    135       Fatty acid-binding protein, epidermal.
FT                                /FTId=PRO_0000067377.
FT   REGION      129    131       Fatty acid binding. {ECO:0000250}.
FT   BINDING     109    109       Fatty acid. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES      17     17       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     131    131       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   DISULFID    120    127       {ECO:0000269|PubMed:10493790,
FT                                ECO:0000269|PubMed:12049637}.
FT   HELIX         4      7       {ECO:0000244|PDB:5HZ5}.
FT   STRAND        9     18       {ECO:0000244|PDB:5HZ5}.
FT   HELIX        19     25       {ECO:0000244|PDB:5HZ5}.
FT   HELIX        30     38       {ECO:0000244|PDB:5HZ5}.
FT   STRAND       42     48       {ECO:0000244|PDB:5HZ5}.
FT   STRAND       51     57       {ECO:0000244|PDB:5HZ5}.
FT   STRAND       63     68       {ECO:0000244|PDB:5HZ5}.
FT   STRAND       73     76       {ECO:0000244|PDB:5HZ5}.
FT   STRAND       78     80       {ECO:0000244|PDB:1JJJ}.
FT   STRAND       82     90       {ECO:0000244|PDB:5HZ5}.
FT   STRAND       93    100       {ECO:0000244|PDB:5HZ5}.
FT   STRAND      103    112       {ECO:0000244|PDB:5HZ5}.
FT   STRAND      115    122       {ECO:0000244|PDB:5HZ5}.
FT   STRAND      125    134       {ECO:0000244|PDB:5HZ5}.
SQ   SEQUENCE   135 AA;  15164 MW;  77D38F8806143D63 CRC64;
     MATVQQLEGR WRLVDSKGFD EYMKELGVGI ALRKMGAMAK PDCIITCDGK NLTIKTESTL
     KTTQFSCTLG EKFEETTADG RKTQTVCNFT DGALVQHQEW DGKESTITRK LKDGKLVVEC
     VMNNVTCTRI YEKVE
//
